The therapic effect of the combination of endovascular embolization and hormone in Kasabach-Merritt phenomenon
10.3760/cma.j.issn.1005-1201.2013.03.008
- VernacularTitle:血管内栓塞与激素联合治疗婴幼儿卡梅现象的疗效研究
- Author:
Liangbo XU
;
Lidan WANG
;
Xinxian LIU
;
Fan LIU
;
Jing DING
;
Gang YAO
;
Sui HUANG
- Publication Type:Journal Article
- Keywords:
Hemangioendothelioma;
Embolization,therapeutic;
Hormones
- From:
Chinese Journal of Radiology
2013;(3):231-234
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the therapic effect of the combination of endovascular embolization and clinical hormone in treatment of Kasabach-Merritt phenomenon (KMP),and analyze the advantages.Methods Six cases with KMP from May 2010 to June 2012 were retrospectively analyzed.All the patients underwent large dose hormone shock therapy after admission for 7-10 d.Subsequently,selective endovascular embolization was performed using Seldinger technique under general anesthesia Then,the hormone therapy was continued for 2 weeks after embolization.The platelet count and the effect were recorded.If the area of the tumor reduction is less than 50％,3-4 courses of local hardening treatment was conducted for the residual tumor.The local treatment used multipoint puncturing of the tumor and injection drugs under X-ray fluoroscopic monitoring until the tension of local vascular increased.Results On DSA,the lesions of all the 6 cases showed rich blood supply with a large number of hybrid distribution of tumor blood vessels.The lesions disappeared in 4 cases after 1-2 weeks combination therapy and no recurrence for 0.5-1.0 year follow-up.Two cases whose tumor reduced less than 50％ after combination therapy received local hardening treatment,and faded after 3-4 courses.The number of platelet for all patients kept normal and the spirit of the patients showed great improvement,the bleeding tendency and local soft tissue swelling was in remission.Subcutaneous blood stasis and petechiae disappeared.There were no serious adverse reaction and complications.Conclusion Combination therapy with endovascular embolization and clinical hormone for Kasabach-Merritt phenomenon has a good curative effect.
